36 /100
MEDIUM RISK
Score updated Jul 14, 2026

MHUAF — Meihua International Medical Technologies Co., Ltd. Dilution Risk Tracker

Track MHUAF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MHUAF — Get alerts when the score changes →

As of July 14, 2026, Meihua International Medical Technologies Co., Ltd. (MHUAF) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Meihua International Medical Technologies Co., Ltd. has a market capitalization of $7.19M, 697.9K shares outstanding, 1 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
30%
🔁 Convertible Conversion 60%
• Major convertible overhang: 78% potential dilution
• Convertible risk score very high (85/100)
🔔 Track MHUAF — Get forecast alerts →

💹 Market Data

Market Cap$7.19M
Shares Outstanding697.9K
Float566.0K
Cash$16.93M
Debt$9.71M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 46.4% shares (2026Q1 vs prior)
1 institutional holders · 68.7K shares
#1 Marex Group plc 68.7K shares

📉 Short Interest

Short Interest1.4K
Days to Cover1.7
% of Float0.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MHUAF Shareholders

Meihua International Medical Technologies Co., Ltd. (MHUAF) has a DilutionScore of 36/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for MHUAF shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MHUAF in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MHUAF alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MHUAF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MHUAF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MHUAF
📊 MHUAF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MHUAF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.